Home
HomeChat
Markets
AlertsCalendarScreenerCharts
Portfolio
WatchlistsPortfolioFiles
Account
Docs
Sign upJoinLog inLogin

KALA BIO, Inc. (KALA) stock profile

Kala Bio, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based mucus penetrating particles with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Arlington, MA.

Key facts

SymbolKALA
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CEOAvi Minkowitz
Employees38
HeadquartersArlington, MA, US
IPO2017-07-20
Websitewww.kalarx.com

Explore KALA on Vantafin

  • KALA BIO, Inc. Overview
  • KALA BIO, Inc. Financials
  • KALA BIO, Inc. News
  • KALA BIO, Inc. Events
  • KALA BIO, Inc. SEC filings
  • KALA BIO, Inc. Insider transactions
  • KALA BIO, Inc. Transcripts

Frequently asked questions

What does KALA BIO, Inc. (KALA) do?
Kala Bio, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based mucus penetrating particles with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Arlington, MA.
Where is KALA stock listed?
KALA BIO, Inc. trades under the ticker KALA on NASDAQ.
How can I research KALA's financials and filings?
Vantafin provides KALA BIO, Inc.'s income statement, balance sheet and cash-flow data, SEC filings, earnings-call transcripts, and insider & institutional ownership on the KALA profile.